Exercise-Boosting Molecule May Help Improve Muscle Health in Type 2 Diabetes

A research team led by scientists at the University of Leeds has discovered that a molecule released during exercise, called beta-aminoisobutyric acid (BAIBA), plays a crucial role in strengthening muscles and improving exercise performance. Their study, involving experiments on mice and human plasma analyses, identified L-BAIBA as the primary regulator of muscle adaptation and endurance enhancement in response to exercise training.

Lead researcher Lee Roberts, a professor of molecular physiology and metabolism at the University of Leeds, explained that their findings provide new insights into how exercise benefits the body and highlight a promising target for future therapies aimed at preserving muscle function in chronic conditions like diabetes. The study, published in Nature Communications, suggests that BAIBA may be a valuable therapeutic option for other diseases with skeletal muscle atrophy or dysfunction, such as chronic heart failure, cancer cachexia, or sarcopenia.

Exercise training involves multiple bouts of activity that challenge the body's physiology, leading to adaptations across cells, tissues, and organs. Understanding the molecular mechanisms and signals through which exercise mediates these systemic adaptations could lead to the identification of therapeutic targets and new strategies to treat various diseases, including type 2 diabetes.

The researchers found that L-BAIBA supplementation in mice increased skeletal muscle mitochondrial number and functional capacity, improved muscle contractile function, and induced phenotypic remodeling similar to aerobic exercise training. When combined with exercise training, BAIBA supplementation in mice led to an increased adaptive response in skeletal muscle and protected muscle from damage caused by type 2 diabetes, which can limit a person's quality of life by causing muscle loss, reduced strength, and impaired metabolism.

Improving muscle resistance to fatigue through BAIBA treatment could have transformative effects, as exercise can help manage diabetes. The discovery that BAIBA mimics the adaptive response of muscle to exercise and can translate these benefits to improved muscle and systemic function may have important clinical implications for the future management of type 2 diabetes.